AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 190 filers reported holding AURINIA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.48 and the average weighting 0.1%.
Links
Filings
- All filings
- Annual reports (20-F)
- Quarterly reports (6-K)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $1,458,127 | +17.8% | 150,633 | +50.6% | 0.01% | +20.0% |
Q1 2022 | $1,238,000 | -82.5% | 100,000 | -67.7% | 0.01% | -81.5% |
Q4 2021 | $7,090,000 | +560.1% | 310,000 | +538.9% | 0.03% | +575.0% |
Q3 2021 | $1,074,000 | +75.2% | 48,518 | +2.6% | 0.00% | +33.3% |
Q2 2021 | $613,000 | – | 47,307 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ACT CAPITAL MANAGEMENT, LLC | 188,500 | $4,311,000 | 3.12% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 334,500 | $7,647,000 | 1.70% |
IRONWOOD INVESTMENT MANAGEMENT LLC | 131,760 | $3,013,000 | 1.49% |
NEA Management Company, LLC | 3,069,834 | $70,207,000 | 1.42% |
Berry Street Capital Management LLP | 575,000 | $13,151,000 | 1.36% |
Melqart Asset Management (UK) Ltd | 916,321 | $20,956,000 | 1.06% |
SILVERARC CAPITAL MANAGEMENT, LLC | 100,000 | $2,287,000 | 0.93% |
HighMark Wealth Management LLC | 50,499 | $1,155,000 | 0.73% |
Artal Group S.A. | 1,000,000 | $22,870,000 | 0.62% |
Vigilare Wealth Management | 34,925 | $799,000 | 0.47% |